These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1131576)

  • 1. Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment.
    Boxley JD; Dawber RP; Summerly R
    Br Med J; 1975 May; 2(5965):255-6. PubMed ID: 1131576
    [No Abstract]   [Full Text] [Related]  

  • 2. double-blind"double-bind.
    Björnberg A; Hellgren L
    Curr Med Res Opin; 1975; 3(1):36-8. PubMed ID: 1090417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diprosone ointment in psoriasis. A double-blind trial.
    Ross CM
    S Afr Med J; 1974 Oct; 48(48):2030-2. PubMed ID: 4612753
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
    Jegasothy BV
    Int J Dermatol; 1990 Dec; 29(10):729-30. PubMed ID: 2269571
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionate.
    Walker SR; Wilson L; Fry L; James VH
    Br J Dermatol; 1974 Sep; 91(3):339-43. PubMed ID: 4447661
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical evaluation of a new topical corticosteroid, clobetasol propionate. An international controlled trial.
    Sparkes CG; Wilson L
    Br J Dermatol; 1974 Feb; 90(2):197-203. PubMed ID: 4594577
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis.
    Hellgren L
    Ann Clin Res; 1976 Oct; 8(5):317-9. PubMed ID: 136921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the response of psoriasis, over a 6-month period, to clobetasol propionate and fluocinolone acetonide ointments.
    Floden CH; Woodbridge P; Samman P; Kurwa AR
    Curr Med Res Opin; 1975; 3(6):375-81. PubMed ID: 1183219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of psoriasis to betamethasone valerate and clobetasol propionate. A 6-month controlled study.
    Corbett MF
    Br J Dermatol; 1976 Mar; 94 suppl 12():89-93. PubMed ID: 773414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
    Telfer NR; Dawber RP
    J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
    Blum G; Kröpfli P; Küng D; Suter H
    Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
    [No Abstract]   [Full Text] [Related]  

  • 15. Betamethasone 17-valerate ointment in a lanolin-free base.
    Wilson L
    Curr Med Res Opin; 1973; 1(4):228-32. PubMed ID: 4589630
    [No Abstract]   [Full Text] [Related]  

  • 16. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
    Satake K; Amano T; Okamoto T
    Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
    Roberts DT
    Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
    Marriott PJ; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():101-6. PubMed ID: 1268069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative efficacy of betamethasone dipropionate cream and ointment formulations in the treatment of psoriasis.
    Leer JA
    Cutis; 1979 Jan; 23(1):97-101. PubMed ID: 759126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.